RAVENSCROFT MEDICAL CENTRE — All Prescriptions & Medications — Page 5
Practice Code: E83039 | LONDON, NW11 8BB
Showing results 201-250 of 442
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Calcium carbonate | 59 | 1,560 | £175 | -10.3% ▼ |
| Olopatadine | 59 | 460 | £443 | +34.5% ▲ |
| Clotrimazole | 59 | 1,970 | £115 | -39.1% ▼ |
| Progesterone | 58 | 3,427 | £755 | -86.1% ▼ |
| Febuxostat | 58 | 600 | £50 | +55.3% ▲ |
| Hepatitis A | 58 | 58 | £1.1K | -23.6% ▼ |
| Carvedilol | 57 | 1,726 | £63 | -49.8% ▼ |
| Vildagliptin | 57 | 504 | £154 | +292.8% ▲ |
| Ready to serve 2.4 kcal/ml milkshake lower volume (0913011) | 57 | 293.8K | £4.0K | -54.0% ▼ |
| Amiodarone hydrochloride | 56 | 224 | £18 | -13.2% ▼ |
| Primidone | 56 | 952 | £969 | +57.4% ▲ |
| Dantrolene sodium | 56 | 1,568 | £648 | +210.5% ▲ |
| Diphtheria | 56 | 56 | £410 | -16.1% ▼ |
| Typhoid | 56 | 56 | £581 | -37.8% ▼ |
| Oxybutynin | 55 | 1,484 | £154 | -71.1% ▼ |
| Fluticasone furoate/vilanterol | 54 | 72 | £1.7K | -65.1% ▼ |
| Powder extensively hydrolysed formula (0913101) | 54 | 179.2K | £5.4K | -25.0% ▼ |
| 53 | 335 | £152 | -74.6% ▼ | |
| Isosorbide dinitrate | 52 | 728 | £40 | +189.2% ▲ |
| Rizatriptan | 52 | 405 | £1.4K | -12.5% ▼ |
| Fosfomycin trometamol | 52 | 97 | £448 | +82.7% ▲ |
| Duloxetine hydrochloride | 52 | 932 | £243 | +1.5% vs avg |
| Beclometasone dipropionate | 52 | 64 | £187 | -75.8% ▼ |
| Ispaghula husk | 51 | 3,806 | £662 | -61.3% ▼ |
| Cyclizine hydrochloride | 51 | 2,206 | £78 | -68.4% ▼ |
| Loratadine | 50 | 3,410 | £70 | -76.1% ▼ |
| Norethisterone | 50 | 5,046 | £818 | +3.1% ▲ |
| Hydroxychloroquine sulfate | 50 | 3,191 | £142 | -74.2% ▼ |
| Clobetasol propionate | 50 | 2,710 | £875 | -63.4% ▼ |
| Amorolfine hydrochloride | 50 | 325 | £413 | +116.5% ▲ |
| 50 | 7,300 | £265 | -61.8% ▼ | |
| Peppermint oil | 49 | 7,120 | £577 | -38.4% ▼ |
| Tranexamic acid | 49 | 3,240 | £212 | -42.2% ▼ |
| Biphasic insulin aspart | 49 | 220 | £1.3K | -51.7% ▼ |
| Loperamide hydrochloride | 48 | 3,350 | £71 | -79.4% ▼ |
| Moxonidine | 48 | 336 | £45 | -13.8% ▼ |
| Estriol | 48 | 805 | £1.1K | -77.4% ▼ |
| Neomycin sulfate | 48 | 750 | £95 | -19.0% ▼ |
| Co-amilofruse (Amiloride hydrochloride/frusemide) | 47 | 1,316 | £206 | +35.1% ▲ |
| Nicorandil | 47 | 470 | £59 | -67.4% ▼ |
| Saxagliptin | 47 | 980 | £1.1K | +40.6% ▲ |
| Methotrexate | 47 | 1,268 | £75 | -85.6% ▼ |
| Dexamfetamine sulfate | 45 | 4,116 | £4.1K | +25.2% ▲ |
| Nystatin | 45 | 1,470 | £84 | -55.4% ▼ |
| Testosterone | 45 | 6,040 | £2.5K | -41.0% ▼ |
| Etoricoxib | 45 | 1,932 | £493 | -44.1% ▼ |
| Miconazole nitrate | 45 | 2,100 | £333 | -36.4% ▼ |
| Umeclidinium bromide/vilanterol | 44 | 54 | £1.7K | -77.4% ▼ |
| Celecoxib | 44 | 1,893 | £99 | -33.4% ▼ |
| Bimatoprost | 44 | 297 | £399 | -70.4% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.